← FDA DRUG APPROVALS

FDA NDA · NDA012892

URACIL MUSTARD

Sponsor: SHIRE

APPLICATION
NDA012892
TYPE
NDA
ORIGINAL APPROVAL
1962-09-13
LATEST ACTION
1999-05-06
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

URACIL MUSTARDDiscontinued
URACIL MUSTARD 1MG · CAPSULE · ORAL

Approval history

1999-05-06Labeling · Supplement 15 · priorityLabelAP
1999-05-06Labeling · Supplement 16 · priorityLetterAP
1980-05-13Labeling · Supplement 14 · priorityAP
1979-12-06Labeling · Supplement 13 · priorityAP
1962-09-13Type 1 - New Molecular Entity · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →